Loncastixumab Tesirine (ADCT-402) Expanded Access Program (EAP) for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT04705454 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT04705454
- Sponsor
- ADC Therapeutics S.A.
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.